ABSTET 250MG Tablet contains Abiraterone Acetate, a potent oral medication specifically formulated for the treatment of prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). Abiraterone Acetate functions by selectively inhibiting the CYP17 enzyme, which significantly reduces androgen production in the testes, adrenal glands, and prostate tumor tissues. This reduction in androgen levels effectively controls tumor growth and prolongs patient survival. ABSTET is designed to be administered orally, offering convenience and ease of use in clinical settings. Typically, it is prescribed alongside corticosteroids such as prednisone or prednisolone to enhance therapeutic outcomes and reduce side effects. The standard dosage involves taking four 250 mg tablets (total 1000 mg) once daily on an empty stomach. The medication is available in blister or bottle packaging, containing 120 tablets per pack. Proper storage conditions, including protection from light, moisture, and temperatures below 30°C, are essential to maintain drug efficacy. ABSTET is intended exclusively for use under strict medical supervision with regular monitoring of liver function, potassium levels, and blood pressure to manage safety effectively.

*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.